Cigna Corp (CI)

The Cigna Group is a U.S.-based healthcare company that provides insurance and related products and services through its subsidiaries. Its operations are organized into two segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes pharmacy benefit and specialty care services such as claim adjudication, pharmacy network administration, benefit design support, utilization review, formulary management, home delivery pharmacy, specialty pharmacy, and clinical programs focused on health outcomes. Cigna Healthcare covers U.S. and international health businesses, with offerings that include employer medical plans, individual and family coverage, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, and global health solutions. The company also has other operations, including corporate-owned life insurance, reinsurance, and selected run-off and non-strategic businesses. It markets its products through brokers and consultants, as well as directly to employers, unions, groups, and individuals via private and public exchanges. Founded in 1792 and headquartered in Bloomfield, Connecticut, the company was formerly known as Cigna Corporation until its name change in February 2023.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Payment Date Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-CI
$441.33
57.8% Upside
Bargain
$339.36
21.3% Upside
Undervalued
Great
September 23, 2026
2.2%
October 29, 2026
11.6x
1.7x
0.3x
74.106 B
79.98 B
30.0%
99.5%
4.9
25.3%
142.0%
Valuation • Fair Value

Cigna Corp (NYSE-CI) Fair Value by Valuation Model

Review the available estimates for Cigna Corp (NYSE-CI), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$441.33

Estimated upside of 57.8% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$525.10

Discounted cash flow valuation reference.

Ben Graham Formula Value

$269.41

Classic Ben Graham valuation formula reference.

DDM Fair Value

$560.36

Dividend discount model valuation reference.

Comps Fair Value

$351.69

Comparable-company valuation reference.

Analyst Price Target

$339.36

Analysts imply upside of 21.3%.

How to read these valuation models

Use the 7 available valuation references for Cigna Corp (NYSE-CI) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Cigna Corp (NYSE-CI)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

282.4 B

Current operating scale indicator.

Revenue Forecast

286.5 B

Forward revenue estimate.

EBITDA

12.758 B

Current operating profitability reference.

EBITDA Forecast

13.009 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Cigna Corp (NYSE-CI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Cigna Corp (NYSE-CI)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.51

No elevated caution signal from this screen.

Altman Z-Score

4.9

Relatively strong balance-sheet zone.

FCF / Net Income

142.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Cigna Corp (NYSE-CI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Cigna Corp (NYSE-CI)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

October 29, 2026

Days to Earnings

42

Dividend Payment Date

September 23, 2026

Dividend Yield

2.2%

Current income yield reference.

Payout Ratio

25.3%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Cigna Corp (NYSE-CI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Cigna Corp (NYSE-CI) Stock Forecast & Technical Outlook

Review Cigna Corp (NYSE-CI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Cigna Corp (NYSE-CI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Cigna Corp (NYSE-CI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Cigna Corp (NYSE-CI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Cigna Corp (NYSE-CI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Cigna Corp (NYSE-CI) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Cigna Corp (NYSE-CI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Cigna Corp (NYSE-CI) has a Buy consensus, with 13 buy, 6 hold and 0 sell recommendations in the current data set.

Buy 13
Hold 6
Sell 0
FAQ Fast Investor Answers

Cigna Corp (NYSE-CI) Stock FAQ

Data-supported answers about Cigna Corp (NYSE-CI), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$441.33
Estimated upside 57.8%
Valuation Rating
Undervalued
Estimated upside of 57.8%
Analyst Target
$339.36
Implied upside 21.3%
Financial Health
Great
Current financial-health read

The current fair value estimate for Cigna Corp (NYSE-CI) is $441.33. This implies an estimated upside of 57.8% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 57.8% versus the current market price.

The available analyst price target for Cigna Corp (NYSE-CI) is $339.36. The analyst target implies estimated upside of 21.3%.

The current financial health read for Cigna Corp (NYSE-CI) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Cigna Corp (NYSE-CI) is October 29, 2026.

Based on the current data, dividend yield is 2.2%, payment date is September 23, 2026.

The current P/E ratio listed for Cigna Corp (NYSE-CI) is 11.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Cigna Corp is 74.106 B.

The current enterprise value listed for Cigna Corp is 79.98 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Cigna Corp is NYSE-CI, and the stock is listed on NYSE.

Cigna Corp (NYSE-CI) is listed on NYSE.

The current debt-to-total-capital ratio listed for Cigna Corp is 30.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Cigna Corp is 99.5%. Free float helps investors understand how much of the share base is available for public trading.